Latest Breaking News On - United states biological - Page 8 : comparemela.com

The Increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry-academia collaborations, and the patent expiry of biologics are the major factors driving the growth of the market. In 2020, the growth factors & chemokines segment accounted for the largest share of the market and is also expected to grow at the highest CAGR during the forecast period. Based on product, the recombinant proteins market is classified into growth factors and chemokines, structural proteins, kinase proteins, regulatory proteins, membrane proteins, recombinant metabolic enzymes, adhesion molecules and receptors, immune response proteins, and other recombinant proteins. The large share of the growth factors and chemokines segment can be attributed to its use in various research areas such as chemotaxis, neurobiology, wound healing, immunology, transplantation, apoptosis, cancer, HIV/AIDS, COVID-19, cell culture, and stem cell research.

United statesUnited kingdomSouth koreaAsia pacificAashish mehraAbnova corporation taiwanBioscience incBiotechnology market research reports consultingSino biological incResearch antibodies reagents marketProteintech group incAviva systems biology corporationResearch areaRaybiotech incEnd user biotechnology companiesTechnogene ltd